Skip to main content
. 2007 May 25;6(10):569–577. doi: 10.1111/j.1524-6175.2004.02632.x

Figure 3.

Figure 3

Mean placebo‐adjusted change from baseline in diastolic blood pressure (DBP) in subjects with hypertension treated at maximal marketed doses of an angiotensin receptor blocker plus hydrochlorothiazide (HCTZ) for 8 weeks. *highest dose reported in the published paper; ITT population not reported in this study